Monsenso A/S (CPH:MONSO)
Denmark · Delayed Price · Currency is DKK 0.4600
-0.0020 (-0.43%)
Jun 18, 2026, 9:00 AM CET
Monsenso Market Cap
Monsenso has a market cap or net worth of 44.31 million as of June 17, 2026. Its market cap has increased by 155.22% in one year.
Market Cap
44.31M
Enterprise Value
46.10M
Revenue
8.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.46
Market Cap Chart
Since June 10, 2020, Monsenso's market cap has decreased from 96.87M to 44.31M, a decrease of -54.26%. That is a compound annual growth rate of -12.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 44.31M | 342.38% |
| Dec 30, 2025 | 10.02M | -59.16% |
| Dec 30, 2024 | 24.52M | 177.63% |
| Dec 29, 2023 | 8.83M | -21.75% |
| Dec 30, 2022 | 11.29M | -59.30% |
| Dec 30, 2021 | 27.73M | -82.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.26T |
| Genmab | 97.86B |
| Coloplast | 85.52B |
| ALK-Abelló | 59.73B |
| Gubra | 5.96B |
| BioPorto | 569.38M |
| Pharma Equity Group | 110.23M |
| ViroGates | 98.39M |